Clovis Oncology, Inc. Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
Clovis Oncology, Inc. reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of -$187.51 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-09.
Discontinued › Income Statement › Net Income
us-gaap:ProfitLoss · last filed 2022-11-09
- Clovis Oncology, Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2022-09-30 was -$56.02M.
- Clovis Oncology, Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2022-06-30 was -$71.33M.
- Clovis Oncology, Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2022-03-31 was -$60.17M.
- Clovis Oncology, Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2021-12-31 was -$64.39M.
- Clovis Oncology, Inc. net income (loss), including portion attributable to noncontrolling interest for fiscal 2021 was -$264.52M.
- Clovis Oncology, Inc. net income (loss), including portion attributable to noncontrolling interest for fiscal 2020 was -$369.21M.
- Clovis Oncology, Inc. net income (loss), including portion attributable to noncontrolling interest for fiscal 2019 was -$400.42M.
- Clovis Oncology, Inc. net income (loss), including portion attributable to noncontrolling interest for fiscal 2018 was -$368.01M.
| Period end | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2022-09-30 | -$56.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$127.35M derived: sum of 2 quarters · filed 2022-11-09 | -$187.51M 10-Q · filed 2022-11-09 | -$251.91M derived: sum of 4 quarters · filed 2022-11-09 |
| 2022-06-30 | -$71.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$131.50M 10-Q · filed 2022-08-08 | -$195.89M derived: sum of 3 quarters · filed 2022-08-08 | -$263.30M derived: sum of 4 quarters · filed 2022-11-09 |
| 2022-03-31 | -$60.17M 10-Q · filed 2022-05-05 | -$124.56M derived: sum of 2 quarters · filed 2022-05-05 | -$191.97M derived: sum of 3 quarters · filed 2022-11-09 | -$258.42M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-12-31 | -$64.39M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$131.80M derived: sum of 2 quarters · filed 2022-11-09 | -$198.25M derived: sum of 3 quarters · filed 2022-11-09 | -$264.52M 10-K · filed 2022-02-24 |
| 2021-09-30 | -$67.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$133.86M derived: sum of 2 quarters · filed 2022-11-09 | -$200.13M 10-Q · filed 2022-11-09 | -$299.09M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | -$66.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$132.72M 10-Q · filed 2022-08-08 | -$231.68M derived: sum of 3 quarters · filed 2022-08-08 | -$310.36M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | -$66.28M 10-Q · filed 2022-05-05 | -$165.24M derived: sum of 2 quarters · filed 2022-05-05 | -$243.91M derived: sum of 3 quarters · filed 2022-05-05 | -$336.16M derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | -$98.96M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$177.63M derived: sum of 2 quarters · filed 2022-02-24 | -$269.88M derived: sum of 3 quarters · filed 2022-02-24 | -$369.21M 10-K · filed 2022-02-24 |
| 2020-09-30 | -$78.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | -$170.92M derived: sum of 2 quarters · filed 2021-11-03 | -$270.25M 10-Q · filed 2021-11-03 | -$369.75M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | -$92.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | -$191.58M 10-Q · filed 2021-08-04 | -$291.08M derived: sum of 3 quarters · filed 2022-02-24 | -$385.15M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | -$99.33M 10-Q · filed 2021-05-05 | -$198.83M derived: sum of 2 quarters · filed 2022-02-24 | -$292.91M derived: sum of 3 quarters · filed 2022-02-24 | -$413.33M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | -$99.50M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$193.57M derived: sum of 2 quarters · filed 2022-02-24 | -$314.00M derived: sum of 3 quarters · filed 2022-02-24 | -$400.42M 10-K · filed 2022-02-24 |
| 2019-09-30 | -$94.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$214.50M derived: sum of 2 quarters · filed 2020-11-05 | -$300.92M 10-Q · filed 2020-11-05 | -$400.18M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | -$120.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | -$206.85M 10-Q · filed 2020-08-07 | -$306.11M derived: sum of 3 quarters · filed 2021-02-25 | -$395.97M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | -$86.42M 10-Q · filed 2020-05-06 | -$185.68M derived: sum of 2 quarters · filed 2021-02-25 | -$275.55M derived: sum of 3 quarters · filed 2021-02-25 | -$376.74M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | -$99.26M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$189.12M derived: sum of 2 quarters · filed 2021-02-25 | -$290.31M derived: sum of 3 quarters · filed 2021-02-25 | -$368.01M 10-K · filed 2021-02-25 |
| 2018-09-30 | -$89.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$191.06M derived: sum of 2 quarters · filed 2019-11-07 | -$268.75M 10-Q · filed 2019-11-07 | -$320.63M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-06-30 | -$101.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-02 | -$178.88M 10-Q · filed 2019-08-02 | -$230.77M derived: sum of 3 quarters · filed 2020-02-26 | -$291.43M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-03-31 | -$77.69M 10-Q · filed 2019-05-07 | -$129.58M derived: sum of 2 quarters · filed 2020-02-26 | -$190.24M derived: sum of 3 quarters · filed 2020-02-26 | -$365.63M derived: sum of 4 quarters · filed 2020-02-26 |
| 2017-12-31 | -$51.88M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | -$112.55M derived: sum of 2 quarters · filed 2020-02-26 | -$287.93M derived: sum of 3 quarters · filed 2020-02-26 | -$346.40M 10-K · filed 2020-02-26 |
| 2017-09-30 | -$60.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | -$236.05M derived: sum of 2 quarters · filed 2018-11-01 | -$294.51M 10-Q · filed 2018-11-01 | -$365.24M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-06-30 | -$175.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | -$233.85M 10-Q · filed 2018-08-02 | -$304.58M derived: sum of 3 quarters · filed 2019-02-28 | -$370.27M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-03-31 | -$58.46M 10-Q · filed 2018-05-09 | -$129.19M derived: sum of 2 quarters · filed 2019-02-28 | -$194.89M derived: sum of 3 quarters · filed 2019-02-28 | |
| 2016-12-31 | -$70.73M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | -$136.42M derived: sum of 2 quarters · filed 2019-02-28 | -$349.14M 10-K · filed 2019-02-28 | |
| 2016-09-30 | -$65.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | -$278.41M 10-Q · filed 2017-11-02 | ||
| 2016-06-30 | -$212.71M 10-Q · filed 2017-08-03 | |||
| 2015-12-31 | -$352.86M 10-K · filed 2018-02-27 |